A Case of Myositis of the Deltoid Muscle of the Upper Arm Developing 1 week After Influenza Vaccination: Case Report

Overview

Journal Clin Case Rep

Date 2015 Apr 4

PMID 25838900

Citations 5

Authors

Shunsuke Urayoshi

Satohiro Matsumoto

Hiroyuki Miyatani

Yukio Yoshida

Affiliations

Soon will be listed here.

Abstract

We report a case of an elderly man who developed myositis of the deltoid muscle 8 days after influenza vaccination. Adverse reactions to influenza vaccine are generally immediate reactions. However, delayed-type hypersensitivity reactions, although rare, can occur after routine influenza vaccination.

Citing Articles

Focal myositis: a literature review of clinical and immunopathological aspects.

Pugliese A, Migliorato A, Barbaccia A, Biasini F, Musumeci O, Toscano A Acta Myol. 2024; 43(3):108-113.

PMID: 39468967 PMC: 11537714. DOI: 10.36185/2532-1900-536.

A Rare Case of Toxic Myositis Associated with Influenza Vaccination.

Aslam S, Khan O, Mehrabi J, Mohammadrezaei F, Wilches R, Singh S J Community Hosp Intern Med Perspect. 2024; 14(3):98-101.

PMID: 39036571 PMC: 11259473. DOI: 10.55729/2000-9666.1330.

Isolated Infraspinatus Myositis after Intramuscular Vaccine Administration.

Samuelson E, Bano J, Gould H, Levine R Case Rep Orthop. 2022; 2022:1363462.

PMID: 36034749 PMC: 9410995. DOI: 10.1155/2022/1363462.

Focal Myositis of the Deltoid Muscle: The Role of Magnetic Resonance Imaging for Diagnosis.

Ricks M, Ramsingh V, Cole A, Cox G J Orthop Case Rep. 2022; 11(10):58-60.

PMID: 35415093 PMC: 8930295. DOI: 10.13107/jocr.2021.v11.i10.2468.

Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear.

Babazadeh A, Mohseni Afshar Z, Javanian M, Mohammadnia-Afrouzi M, Karkhah A, Masrour-Roudsari J J Transl Int Med. 2020; 7(4):137-142.

PMID: 32010599 PMC: 6985921. DOI: 10.2478/jtim-2019-0028.

References

Govaert T, Dinant G, Aretz K, Masurel N, Sprenger M, Knottnerus J . Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 1993; 307(6910):988-90. PMC: 1679213. DOI: 10.1136/bmj.307.6910.988. View

Vellozzi C, Burwen D, Dobardzic A, Ball R, Walton K, Haber P . Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine. 2009; 27(15):2114-20. DOI: 10.1016/j.vaccine.2009.01.125. View

Nichol K, Nordin J, Nelson D, Mullooly J, Hak E . Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007; 357(14):1373-81. DOI: 10.1056/NEJMoa070844. View

Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Merens A . Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010. Euro Surveill. 2012; 17(24). View

McMahon A, Iskander J, Haber P, Braun M, Ball R . Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine. 2007; 26(3):427-9. DOI: 10.1016/j.vaccine.2007.10.071. View

Galaj A, Grzesk G, Kuziemski A, Szadujkis-Szadurski L, Sinjab T . [Adverse reactions after vaccination against influenza in chronically ill people]. Pol Merkur Lekarski. 2002; 12(72):496-9. View

Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V . Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005; 366(9492):1165-74. DOI: 10.1016/S0140-6736(05)67339-4. View

Nichol K, Margolis K, Wuorenma J, von Sternberg T . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994; 331(12):778-84. DOI: 10.1056/NEJM199409223311206. View

Nichol K, Margolis K, Lind A, Murdoch M, McFadden R, Hauge M . Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med. 1996; 156(14):1546-50. View

10.

Patrizi A, Rizzoli L, Vincenzi C, Trevisi P, Tosti A . Sensitization to thimerosal in atopic children. Contact Dermatitis. 1999; 40(2):94-7. DOI: 10.1111/j.1600-0536.1999.tb05998.x. View

11.

Maeda K, Idehara R . Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination. Intern Med. 2012; 51(14):1931-3. DOI: 10.2169/internalmedicine.51.7487. View

12.

Salmon D, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen D . Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013; 381(9876):1461-8. DOI: 10.1016/S0140-6736(12)62189-8. View

13.

Cook I, Barr I, Hartel G, Pond D, Hampson A . Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine. 2006; 24(13):2395-402. DOI: 10.1016/j.vaccine.2005.11.057. View

14.

Falsey A, Treanor J, Tornieporth N, Capellan J, Gorse G . Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009; 200(2):172-80. DOI: 10.1086/599790. View

15.

Wood R, Berger M, Dreskin S, Setse R, Engler R, Dekker C . An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics. 2008; 122(3):e771-7. DOI: 10.1542/peds.2008-1002. View